‹ All Posts
RAJIV GUPTA (SEBI RA)

19th Jul · SEBI-Registered Analyst

Q1 FY27 results - Rossari Biotech Ltd

Code BSE: 543213 NSE: $ROSSARI a) Highest-ever quarterly Revenue of Rs. 697.2 crore, up 28% YoY b) Highest-ever quarterly EBITDA of Rs. 80.6 crore, up 19% YoY c) PAT at Rs. 35.1 crore, up 4% YoY Commenting on the performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said " We commenced FY27 on a strong note, delivering robust consolidated revenue growth of 28% YoY. The performance was driven by healthy momentum in the domestic business and the continued expansion of our international presence. Despite a dynamic operating environment, our diversified business model, broad-based market presence and disciplined execution enabled us to deliver growth across all our business segments. ..."

#WatchOutFor#StockInNews
ROSSARI19072026.pdf
772 likes·59 comments